Primary Record
Hydroxy Ritonavir
Note: Only for scientific research or as raw materials for production.
- In stock
- 9,689 g
- Purity
- 99.4 %
- CAS
- 176655-56-4
Compound Identifiers & Properties
- CAS
- 176655-56-4
- PubChem CID
- 71749331
- SMILES
- CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)O)NC(=O)N(C)CC4=CSC(=N4)C(C)(C)O
- Canonical SMILES
- CC(C)[C@H](NC(=O)N(C)Cc1csc(C(C)(C)O)n1)C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1
Names & Synonyms
- Hydroxy Ritonavir
- Hydroxyritonavir
- Ritonavir EP Impurity E
- 176655-56-4
- starbld0024018
- JN1D7K606N
- UNII-JN1D7K606N
- RefChem:1073368
- DTXSID10170167
- RITONAVIR METABOLITE M2
- orb1983207
- CHEMBL3544628
- DTXCID1092658
- SCHEMBL29771356
- Ritonavir specified impurity E [EP]
- CHEBI:172813
- ZINC72131413
- Ritonavir impurity, hydroxyritonavir- [USP]
- MS-31280
- RITONAVIR IMPURITY E [EP IMPURITY]
- HY-137565
- J808.685K
- CS-0140457
- F82775
- 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-2-[[[2-(2-hydroxypropan-2-yl)-1,3-thiazol-4-yl]methyl-methylcarbamoyl]amino]-3-methylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
- A937310
- F987402
- Q27281586
- 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-13-(2-(1-hydroxy-1-methylethyl)-4-thiazolyl)-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)-
- Thiazol-5-ylmethyl ((1S,2S,4S)-1-benzyl-2-hydroxy-4-(((2S)-2-((((2-(1-hydroxy-1-methylethyl)thiazol-4-yl)methyl)methylcarbamoyl)amino)-3-methylbutanoyl)amino)-5-phenylpentyl)carbamate
- Thiazol-5-ylmethyl ((2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-(2-hydroxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate
- RITONAVIR IMPURITY, HYDROXYRITONAVIR- [USP IMPURITY]
- [5S-(5R*,8R*,10R*,11R*)]-10-Hydroxy-1-[2-(1-hydroxy-1-methylethyl)-4-thiazolyl]-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic Acid 5-Thiazolylmethyl Ester
- (1,3-thiazol-5-yl)methyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-2-[({[2-(2-hydroxypropan-2-yl)-1,3-thiazol-4-yl]methyl}(methyl)carbamoyl)amino]-3-methylbutanamido]-1,6-diphenylhexan-2-yl]carbamate
- (3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6-dimethyl-9-(methyl-d3)-3,12-epox-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one
- 1,3-thiazol-5-ylmethyl N-((2S,3S,5S)-3-hydroxy-5-(((2S)-2-(((2-(2-hydroxypropan-2-yl)-1,3-thiazol-4-yl)methyl-methylcarbamoyl)amino)-3-methylbutanoyl)amino)-1,6-diphenylhexan-2-yl)carbamate
- 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-13-[2-(1-hydroxy-1-methylethyl)-4-thiazolyl]-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)-; 2,4,7,12-Tetraazatridecan-13-oic acid, 10-hydroxy-1-[2-(1-hydroxy-1-methylethyl)-4-thiazolyl]-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, [5S-(5R*,8R*,10R*,11R*)]- ; Hydroxy Ritonavir; Thiazol-5-ylmethyl [(1S,2S,4S)-1-Benzyl-2-hydroxy-4-[[(2S)-2-[[[[2-(1-hydroxy-1-methylethyl)thiazol-4-yl]methyl]methyl-carbamoyl]amino]-3-methylbutanoyl]amino]-5-phenylpentyl]carbamate; Ritonavir Imp. E (EP)
- 5-Thiazolylmethyl (3S,4S,6S,9S)-4-hydroxy-13-(2-(1-hydroxy-1-methylethyl)-4-thiazolyl)-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoate
- 5-Thiazolylmethyl (3S,4S,6S,9S)-4-hydroxy-13-[2-(1-hydroxy-1-methylethyl)-4-thiazolyl]-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoate
- N-[(1S,2S,4S)-1-Benzyl-2-hydroxy-4-[[(S)-2-[3-methyl-3-[[2-(1-hydroxy-1-methylethyl)-4-thiazolyl]methyl]ureido]-1-oxo-3-methylbutyl]amino]-5-phenylpentyl]carbamic acid 5-thiazolylmethyl ester
- N-[(2S,4S,5S)-4-Hydroxy-1,6-diphenyl-5-({[(1,3-thiazol-5-yl)methoxy]carbonyl}amino)hexan-2-yl]-N~2~-[{[2-(2-hydroxypropan-2-yl)-1,3-thiazol-4-yl]methyl}(methyl)carbamoyl]-L-valinamide